8 hasil untuk "Sandipta Kumar Panda"

Bradycardia in Severe Plasmodium vivax Malaria

Prabhat Kumar Agrawal; Sandipta Kumar Panda; Shiv Sagar Yadav

Journal of Global Infectious Diseases, Vol. 17 No. 1 · 2025 · Inggris · DOAJ Scopus

A Rare Case Report of Vildagliptin-Induced Gingival Hyperplasia

Prabhat Kumar Agrawal; Nagendra Kumar Singh; Sandipta Kumar Panda dkk.

Journal of Diabetology, Vol. 16 No. 3 · 2025 · Inggris · DOAJ Scopus

Globally, the burden of diabetes is huge and is on the rise. In developing countries like India, the prevalence of diabetes is rising alarmingly owing to the continuously rising prevalence of obesity, unhealthy lifestyles, and other environmental factors. Vildagliptin is a widely prescribed oral…

Beyond the usual spectrum: Atrial septal defect in a Marfan syndrome patient with severe aortic pathologies

Prabhat Kumar Agrawal; Siddhant Dev; Sandipta Kumar Panda dkk.

Journal of Family Medicine and Primary Care, Vol. 14 No. 9 · 2025 · Inggris · DOAJ

Marfan’s syndrome is a rare connective tissue disorder which mainly affects cardiovascular, skeletal, and ocular systems. Common cardiovascular manifestation of Marfan’s includes aortic root dilatation, aortic regurgitation, and mitral valve prolapse. However, presence of congenital heart defects…

Antidepressant-induced Hyponatremia in Postmenopausal Females: A Case Series

Prabhat Kumar Agrawal; Sandipta Kumar Panda; Shiv Sagar Yadav dkk.

Journal of Mid-Life Health, Vol. 15 No. 4 · 2024 · Inggris · DOAJ Scopus

Hyponatremia is the most common electrolyte imbalance observed in hospitalized as well as outdoor patients. Antidepressants such as selective serotonin receptor inhibitors and tricyclic antidepressants are reported among the most common drugs causing hyponatremia, especially in the elderly and in…

Impact of Proton Pump Inhibitors on Blood Glucose in Type 2 Diabetes: A Systematic Review with Meta-analysis

Prabhat Kumar Agrawal; Amit Varshney; Siddhant Dev dkk.

Journal of Mid-Life Health, Vol. 17 No. 2 · 2026 · Inggris · DOAJ Scopus

Proton pump inhibitors (PPIs) are widely prescribed for acid-related disorders, but emerging evidence suggests they may influence glucose metabolism. This meta-analysis evaluates the effect of PPIs on glycemic control in patients with and without type 2 diabetes mellitus (T2DM). We systematically…

Tirzepatide-induced Weight Loss in Overweight or Obese Midlife Adults with and without Type 2 Diabetes: A Real-world Comparative Cohort Study

Prabhat Kumar Agrawal; Shambo Samrat Samajdar; Ruchika Garg dkk.

Journal of Mid-Life Health, Vol. 17 No. 1 · 2026 · Inggris · DOAJ Scopus

Background: Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist, has demonstrated robust weight loss and glycemic benefits in randomized controlled trials. However, real-world data comparing its effectiveness and tolerability in obese adults…

Safety and Efficacy of Imeglimin in Type 2 Diabetes Individuals with Metformin Intolerance: A Case-Control Study

Prabhat Agrawal; Ashish Gautam; Chandra Prakash dkk.

Clinical Diabetology, Vol. 14 No. 3 · 2025 · Inggris · DOAJ Scopus

OBJECTIVE: Metformin is recommended as first-line treatment for type 2 diabetes (T2D), but its adverse gastrointestinal (GI) effects often lead to discontinuation. Imeglimin, a new drug like metformin, has been approved in several countries. This study evaluates the efficacy and safety of imeglimin…

Association of Serum Prolactin Levels in Patients with Type 2 Diabetes Mellitus with and without Diabetic Nephropathy

Krishnan Kirubhakar; Subhash Chandra; Prabhat Kumar Agrawal dkk.

Journal of Diabetology, Vol. 17 No. 1 · 2026 · Inggris · DOAJ Scopus

Introduction: Diabetic nephropathy (DN), a common microvascular complication of type 2 diabetes mellitus (T2DM), contributes significantly to chronic kidney disease and is associated with increased morbidity. Prolactin (PRL), a hormone classically linked with lactation, has emerging roles in…